CorreaP, 1995.Helicobacter pylori and gastric carcinogenesis,Am J Surg Pathol 19 S37 -43
HuangJQ,SridharS,ChenY,HuntRH, 1998.Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer,Gastroenterology 114 1169 -79
EslickGD,LimLL,BylesJE,XiaHH,TalleyNJ, 1999.Association of Helicobacter pylori infection with gastric carcinoma: A metaanalysis,Am J Gastroenterol 94 2373 -9
1994.4. Infection with Helicobacter pylori,IARC Monogr Eval Carcinog Risks Hum 61 177 -240
SipponenP,KekkiM,HaapakoskiJ,IhamakiT,SiuralaM., 1985.Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data,Int J Cancer 35 173 -7
ChoSJ,ChoiIJ,KimCG,KookMC,LeeJY,KimBC, 2010.Risk factors associated with gastric cancer in patients with a duodenal ulcer,Helicobacter 15 516 -23
KimuraK,SatohK,IdoK,TaniguchiY,TakimotoT,TakemotoT., 1996.Gastritis in the Japanese stomach,Scand J Gastroenterol 214 17 -20
YiqiDu,Xiaohua Hou, 2014.Chronic gastritis in China: A national multicenter survey,BMC Gastroenterology 14 21 -
QuachDT,LeHM,HiyamaT,NguyenOT,NguyenTS,UemuraN., 2012.Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia,Helicobacter 18 151 -7
EshmuratovA,NahJC,KimN,LeeHS,LeeHE,LeeBH, 2010.The correlation of endoscopic and histological diagnosis of gastric atrophy,Dig Dis Sci 55 1364 -75
LimJH,KimN,LeeHS,ChoeG,JoSY,ChonI, 2013.Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia,Gut Liver 7 41 -50
de VriesAC,HaringsmaJ,KuipersEJ, 2007.The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection,Helicobacter 12 1 -15
FilipeMI,MuñozN,MatkoI,KatoI,Pompe-KirnV,JutersekA, 1994.Intestinal metaplasia type and the risk of gastric cancer: A cohort study in Slovenia,Int J Cancer 57 324 -9
ReisCA,DavidL,CorreaP,CarneiroF,de BolósC,GarciaE, 1999.Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression,Cancer Res 59 1003 -7
El-ZimaityHMT,RamchatesinghJ,SaeedMA,GrahamDY, 2001.Gastric intestinal metaplasia: Subtypes and natural history,J Clin Pathol 54 679 -83
KimN,ParkRY,ChoSI,LimSH,LeeKH,LeeW, 2008.Helicobacter pylori infection and development of gastric cancer in Korea: Long-term follow-up,J Clin Gastroenterol 42 448 -54
LiuQ,TehM,ItoK,ShahN,ItoY,YeohKG, 2007.CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer,Mod Pathol 20 1286 -97
CamiloV,BarrosR,SousaS,MagalhãesAM,LopesT,Mário SantosA, 2012.Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells,Carcinogenesis 33 1985 -92
BarrosR,PereiraB,DulucI,AzevedoM,MendesN,CamiloV, 2008.Key elements of the BMP/SMAD pathway colocalize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines,J Pathol 215 411 -20
LiB,LiuHY,GuoSH,SunP,GongFM,JiaBQ, 2015.Microsatellite instability of gastric cancer and precancerous lesions,Int J Clin Exp Med 8 21138 -44
LeungWK,KimJJ,KimJG,GrahamDY,SepulvedaAR, 2000.Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer,Am J Pathol 156 537 -43
KatsoulidisE,MavrommatisE,WoodardJ,ShieldsMA,SassanoA,CarayolN, 2010.Role of interferon alfa inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells,J Biol Chem 285 40333 -41
Companioni NápolesO,TsaoAC,Sanz-AnquelaJM,SalaN,BonetC,PardoML, .SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer,J Gastroenterol 1202-4. -
RodierF,CampisiJ,BhaumikD, 2007.Two faces of p53: Aging and tumor suppression,Nucleic Acids Res 35 7475 -84
WuMS,ShunCT,LeeWC,ChenCJ,WangHP,LeeWJ, 1998.Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer,Br J Cancer 78 971 -3
AnagnostopoulosGK,StefanouD,ArkoumaniE,KaragiannisJ,ParaskevaK,ChalkleyL, 2008.Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions,J Gastroenterol Hepatol 23 626 -31
Zhong-YueXiao,Jiang-TaoSun,She-GanGao,Li-Dong Wang, 2012.Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis,Asian Pacific J Cancer Prev 13 247 -50
DasKM,SakamakiS,VecchiM,DiamondB., 1987.The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: Cellular localization of the antigen using the monoclonal antibody,J Immunol 139 77 -84
MirzaZK,DasKK,SlateJ,MapitigamaRN,AmentaPS,GriffelLH, 2003.Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma,Gut 52 807 -12
BertuccioP,ChatenoudL,LeviF,PraudD,FerlayJ,NegriE, 2009.Recent patterns in gastric cancer : A global overview,Int J Cancer 125 666 -73
YangL, 2006.Incidence and mortality of gastric cancer in China,World J Gastroenterol 12 17 -20
ChenSL,MoJZ,CaoZJ,ChenXU,Shu-Dong Xiao, 2005.Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis,World J Gastroenterol 11 2834 -7
LeungWK,EndersKW,WingY,ChanWY,AlexCM,ChanK, 2005.Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients,Cancer Epidemiol Biomarkers Prev 14 12 -
Dias-NetoM,PintalhãoM,FerreiraM,LunetN., 2010.Salt intake and risk of gastric intestinal metaplasia: Systematic review and meta-analysis,Nutr Cancer 62 133 -47
RussoA,MaconiG,SpinelliP,FeliceGD,EboliM,AndreolaS, 2001.Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects,Am J Gastroenterol 96 1402 -8
CompareD,RoccoA,NardoneG, 2010.Risk factors in gastric cancer,Riv Eur Sci Med Farmacol 14 302 -8
PeleteiroB,BastosJ,BarrosH,LunetN., 2008.Systematic review of the prevalence of gastric intestinal metaplasia and its arealevel association with smoking,Gac Sanit 22 236 -47
ChenS,YingL,KongM,ZhangY,LiY., 2013.The prevalence of Helicobacter pylori infection decreases with older age in atrophic gastritis,Gastroenterol Res Pract 494783 -
OlmezS,AslanM,ErtenR,SayarS,BayramI., 2015.The prevalence of gastric intestinal metaplasia and distribution of Helicobacter pylori infection, atrophy, dysplasia, and cancer in its subtypes,Gastroenterol Res Pract 434039 -
LiyaZ,SanrenL,ShigangD,XuebiaoH,ZhuJ,RongliC, 2014.Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: A 10-year follow-up study,Chin Med J 127 8 -
KodamaM,MurakamiK,OkimotoT,AbeT,NakagawaY,MizukamiK, 2012.Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation,Digestion 85 126 -30
KodamaM,MurakamiK,OkimotoT,SatoR,UchidaM,AbeT, 2012.Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication,J Gastroenterol 47 394 -403
ToyokawaT,SuwakiK,MiyakeY,NakatsuM,AndoM., 2010.Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long-term prospective cohort study,J Gastroenterol Hepatol 25 544 -7
LahnerE,BordiC,CattaruzzaMS,IannoniC,MilioneM,Delle FaveG, 2005.Long-term follow-up in atrophic body gastritis patients: Atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection,Aliment Pharmacol Ther 22 471 -81
LeyC,MoharA,GuarnerJ, 2004.Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial,Cancer Epidemiol Biomarkers Prev 13 4 -10
ItoM,HarumaK,KamadaT,MiharaM,KimS,KitadaiY, 2002.Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis,Aliment Pharmacol Ther 16 1449 -56
LeeY,JeonYC,KooTY,ChoHS,ByunTJ,KimTY, 2007.Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication,Korean J Gastroenterol 50 299 -305
WatariJ,ChenN,AmentaPS,FukuiH,OshimaT,TomitaT, 2014.Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development,World J Gastroenterol 20 5461 -73
TavaF,LuinettiO,GhignaMR,AlvisiC,PeregoM,TrespiE, 2006.Type or extension of intestinal metaplasia and immature/ atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia,Hum Pathol 37 1489 -97
HirotaWK,ZuckermanMJ,AdlerDG,DavilaRE,EganJ,LeightonJA, 2006.ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract,Gastrointest Endosc 63 570 -80
Dinis-RibeiroM,AreiaM,de VriesAC,Marcos-PintoR,Monteiro-SoaresM,O'ConnorA, 2012.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED),Endoscopy 44 74 -94
SuganoK,TackJ,KuipersEJ,GrahamDY,El-OmarEM,MiuraS, 2015.,Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64 1353 -67
WatabeH,MitsushimaT,YamajiY,OkamotoM,WadaR,KokuboT, 2005.Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study,Gut 54 764 -8